Drug Topics

Monthly news magazine reports on all phases of pharmacy for community and health-system pharmacists. Concise, easy-to-read news reports cover managed care trends, professional issues, national and state governmental activities, new prescription drugs, OTCs, and new merchandising and marketing techniques.

Articles from Vol. 151, No. 23, December 10

An Interview with Larry Kocot: Lessons from CMS
In July, Larry Kocot, former senior advisor to the administrator at Centers for Medicare & Medicaid Services, joined the Brookings Institution's economic studies program as a visiting fellow and deputy director of the Engelberg Center for Health...
Beneficiary Participation in MTM Services
There was some uncertainty at the outset about whether the Medicare Part D program would attract an adequate number of health plans as participants. At the direction of Congress, CMS was careful not to offer plan premiums at levels that would discourage...
Fair or Foul?
An exclusive survey of pharmacists reveals which way they think the winds will blow in 2008Judy ChiIf a weather analogy can be used, do you expect your business conditions to be sunny or storm-ridden in 2008? No one knows how next year will turn out,...
FDA Hears Mixed Views on Third Class of Drugs
Pharmacists' organizations were out in force at a recent Food & Drug Administration hearing on the possibility of creating a third category of drugs that would be placed "behind the counter (BTC)" and sold with pharmacist assistance.Most of the 11...
FDA's Stand on Compounding Is Bad for R.Ph.S and Patients
Your local compounding pharmacist is a criminal. That's the Food & Drug Administration's real position, despite assertions by an agency official who proclaimed that the FDA is "most emphatically not against compounding of drugs" at the recent National...
Here's a 'Smart' Way to Identify IV Pumps
Bob Braverman loves a challenge. Earlier this year, Lancaster General Hospital, a 590-bed facility in Pennsylvania Dutch Country, presented Bravermans company, Medi-Dose Inc., with a unique challenge. "They already used Medi-Dose products to label and...
Keeping an Eye on the AMD Market
As the average age of Americans increases, so too will the incidence of age-related macular degeneration (AMD). The condition currently affects over eight million people in the United States, according to the National Eye Institute. Available treatment...
Letters
Lost in translation: Immigrants should adaptI just read your Nov. 2 on-line daily news article entitled "Complaint filed against pharmacies for absence of translation." Interesting article. Then I got to thinking, Where are we talking about? I soon realized...
Manufacturers Are Putting a New Spin on OTCs
Manufacturers are hurrying to introduce OTCs that have unique or enhanced formulations. Here's a roundup of the latest offerings:Supplements and vitamins* From Wyeth Consumer Healthcare comes Centrum Cardio. The firm claims the multivitamin can lower...
Many Pharmacies Not Ready for DMEPOS Accreditation
For many pharmacists, the Medicare Modernization Act is the gift that keeps on giving. Just beginning to recover from the changes wrought by the Medicare Part D program, and worried about the expected impact of the average manufacturer price rule, many...
Natural Medicines for Bone Health
The popularity and perceived benefits of natural supplements in maintaining good bone health highlight the need for better understanding of the mechanism of actions, adverse effects, proper use, and potential interactions of these products with prescription...
New Products
RxNEW DRUGSAllergan Inc., Irvine, Calif., (714) 246-4500, has FDA approval for Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5%. As an alpha adrenergic receptor agonist/beta adrenergic receptor inhibitor combination, Combigan...
New Trials May Cut Clopidogrel Use
Atrio of late-breaking clinical trials could change standard drug treatment for patients undergoing percutaneous coronary intervention, or PCI. Dual antiplatelet therapy, aspirin plus a thienopyridine, is standard to prevent dirombotic complications...
Pharmacy Professor Bridges the Alzheimer's Divide
Working with Alzheimer's disease patients may not be easy, but colleagues of Robert Cluxton, Pharm.D., insist that he makes it look as though it is. "There are some really good academic pharmacists and some really good clinical pharmacists," explained...
R.Ph. Named Director of UConn's Evidence-Based Practice Center
The Agency for Healthcare Research & Quality (AHRQ) recently awarded the University of Connecticut a five-year contract and up to $ 1 million per year to establish a new Evidence-based Practice Center (EPC). The center will evaluate different drug...
R.Ph.S' Prescribing Impact to Reach $145 Billion by 2012
Do pharmacists have an Rx impact? Yes, and it's growing, according to a recent analysis from Kalorama Information, a market research firm. According to the study, "Prescribing Pharmacists: An Emerging Decision Maker," pharmacists already directly influence...
Special(ty) Delivery
Pharmacy directors see the 2008 pipeline chock-full of specialty drugs and compoundsIf there were one word to characterize potential new drug approvals for 2008, or for the foreseeable future, it would most likely be specially. Generally described as...
Stirring Up Interest in Christmas
Editor's note: Throughout 2007, this column has appeared in each issue as part of our sesquicentennial celebration, and tied with the column is a contest. Monthly questions based on this column have been posted on the Drug Topics anniversary microsite....
This Breast Cancer Drug Is First in New Class of Chemo Agents
Breast cancer patients who have progressed through currently available chemotherapy will now have another treatment option at their disposal. Ixabepilone (Ixempra), from Bristol-Myers Squibb, was recently approved by the Food & Drug Administration...
Will Holiday 2007 Sales Be Lean or Green?
Slumping home prices. High consumer debt. Tight credit. The war in Iraq ... Consumers have ample cause to be jittery about spending freely on holiday gifts.The National Retail Federation's (NRF) annual Holiday Consumer Intentions and Actions Survey offers...
Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.